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Repurposing NGO data for better research
outcomes: a scoping review of the use and
secondary analysis of NGO data in health
policy and systems research
Sarah C. Masefield1,2* , Alice Megaw2, Matt Barlow2,3, Piran C. L. White2,4, Henrice Altink2,5 and Jean Grugel2,3
Abstract
Background: Non-governmental organisations (NGOs) collect and generate vast amounts of potentially rich data,
most of which are not used for research purposes. Secondary analysis of NGO data (their use and analysis in a
study for which they were not originally collected) presents an important but largely unrealised opportunity to
provide new research insights in critical areas, including the evaluation of health policy and programmes.
Methods: A scoping review of the published literature was performed to identify the extent to which secondary
analysis of NGO data has been used in health policy and systems research (HPSR). A tiered analytical approach
provided a comprehensive overview and descriptive analyses of the studies that (1) used data produced or
collected by or about NGOs; (2) performed secondary analysis of the NGO data (beyond the use of an NGO report
as a supporting reference); and (3) analysed NGO-collected clinical data.
Results: Of the 156 studies that performed secondary analysis of NGO-produced or collected data, 64% (n = 100)
used NGO-produced reports (mostly to a limited extent, as a contextual reference or to critique NGO activities) and
8% (n = 13) analysed NGO-collected clinical data. Of these studies, 55% (n = 86) investigated service delivery
research topics and 48% (n = 51) were undertaken in developing countries and 17% (n = 27) in both developing
and developed countries. NGOs were authors or co-authors of 26% of the studies. NGO-collected clinical data
enabled HPSR within marginalised groups (e.g. migrants, people in conflict-affected areas), albeit with some
limitations such as inconsistent and missing data.
Conclusion: We found evidence that NGO-collected and produced data are most commonly perceived as a
source of supporting evidence for HPSR and not as primary source data. However, these data can facilitate
research in under-researched marginalised groups and in contexts that are hard to reach by academics such
as conflict-affected areas. NGO–academic collaboration could help address issues of NGO data quality to
facilitate their more widespread use in research. The use of NGO data use could enable relevant and timely
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research in the areas of programme evaluation and health policy and advocacy to improve health and reduce
health inequalities, especially in marginalised groups and developing countries.
Keywords: Non-government organisations, Health policy and systems research, Developing countries,
Secondary data analysis, Marginalised groups, Sustainable development goals
Background
The lower estimate of the number of non-governmental
organisations (NGOs; non-profit groups formed volun-
tarily) in the world is 1 million, but there may be as
many as 10.3 million (based on the number of registra-
tions of .org and .ngo domain names) [1, 2]. An esti-
mated 35,000 are large, established NGOs and many
operate in the health sector; in the year 2000, there were
over 2000 international health NGOs and this number is
expected to have increased since [3, 4]. These NGOs
deliver, monitor and advocate for health services and
equitable healthcare at the community, national and
international levels [4, 5]. To a lesser extent, they are en-
gaged in performing and disseminating research [1, 6, 7].
Health policy and systems research (HPSR) is a multi-
disciplinary field of research conducted to inform and
influence policies and systems to improve health out-
comes for all [8, 9]. Within the context of HPSR, NGOs
necessarily produce data on the services and programmes
they deliver, collect data on the (often marginalised and
hard to reach by researchers) recipient populations and
the health conditions being treated [10, 11]. These data
can be patient records for populations who do not access
national healthcare, administrative data on the number of
drugs dispensed or days that patients spent in NGO-run
healthcare facilities, data on community responses to
health crises (e.g. in the aftermath of extreme weather
events), or reviews of health policy [12]. Although NGOs
are only rarely collecting data for the purposes of research,
the records and data held by them are a vast (and largely
untapped) source of potentially rich data [6].
NGO-collected data are especially valuable for research
in developing countries, on populations under-served by
the national health system, and where there may be a data
gap due to inadequate national data collection and moni-
toring infrastructure [6, 13, 14]. The analysis of NGO data
presents an opportunity for researchers to conduct rele-
vant, timely and relatively cheap secondary research that
has the potential to improve health outcomes [6, 15–17].
However, there is a dual problem of these data being
ignored by researchers and not made available by NGOs
for secondary analysis [6, 18, 19]. Although some exam-
ples of NGO–academic collaboration and open access
repositories for NGO data exist [11, 20, 21], at other
times, researchers will have to approach NGOs to request
access to data about them or collected by them [22, 23].
HPSR is led largely by questions from ‘the field’ rather
than being theory driven but conceptual frameworks are
used to describe and analyse the health systems studied
[24]. For example, the WHO framework of the six health
system building blocks required to improve health and
health equity uses the categories of (1) service delivery;
(2) healthcare workforce; (3) information; (4) medical
products, vaccines and technologies; (5) financing; and
(6) leadership and governance [25]. The framework is
widely used in HPSR, particularly in developing country
contexts, as it helps locate, describe and classify health
system constraints, where investment is needed, and
how change can be monitored [24, 26–30].
Although the WHO framework has received some
criticism (e.g. a lack of inter-connectedness between the
blocks and a failure to place healthcare recipients at the
centre of the health system), it remains widely used in
HPSR as it is founded on the human right of the highest
standard of physical and mental health and reinforces
improved implementation (universal access to efficient
health services) as the research outcome [25, 29, 31].
NGO data, which are, by their nature, collected in ‘the
field’, therefore have considerable potential to inform
and improve research into the questions asked in HPSR
[7, 32]. We used the WHO building blocks framework
to assess the appropriateness of studies for our scoping
review as it would enable a broad overview of the differ-
ent areas of HPSR in which NGO data are used and we
expected most of the studies in our review to use data
from developing countries [33].
Secondary analysis is the analysis of qualitative or quan-
titative data not produced or collected for the study in
which they are later used [34, 35]. The secondary analysis
of data collected, generated or about health NGOs can
provide valuable insights into healthcare practice, high-
light discontinuity between policy and practice, demon-
strate inequitable access to healthcare, and show changes
over time [18, 36]. For example, data from the patient re-
cords of NGO-run health facilities can be compared with
those of government-run facilities [37]. These compari-
sons can highlight differences in the health and services
available to populations with different sociodemographic,
health or other characteristics [37, 38]. However, second-
ary analysis of NGO data is used infrequently in academic
research in general and in HPSR in particular [10, 15, 39].
To our knowledge, there have been no previous studies
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on what HPSR has been conducted through secondary
analysis of NGO data with a view to making recommenda-
tions to prevent the ongoing underuse of these valuable
sources of information.
Health NGOs act in the public arena to improve the
health and represent the health-related interests of specific
groups of people or of society as a whole. Their most
common undertaking is health service delivery. They are
frequently commissioned by public authorities to provide
services or they identify and meet the service needs of a
particular and often marginalised population group (we
use the term ‘marginalised groups’ to include vulnerable
and hard-to-reach population groups), whilst the public
health system provides more generic services [40]. In
many countries in the global south, whilst universal health
coverage may be the stated aim of health systems [41], in
locations or disease areas with low national health system
coverage, private and NGO providers frequently step in.
For example, in Malawi, the government provides 62% of
health services, with 37% being provided by the NGO
Christian Health Association of Malawi [42, 43]. In areas
affected by conflict or natural disasters, NGOs often oper-
ate as an emergency health system until there is sufficient
stability for public services to be reinstated or NGO
services are scaled up through NGO–public/private
collaboration [44]. NGO data can therefore sometimes be
the only data available in some settings or for certain
population groups [44, 45].
NGOs can also perform an essential monitoring func-
tion – assessing the scale of healthcare needs and identi-
fying the disease and related healthcare priorities and
issues in accessing health services [26]. This can be espe-
cially important for settings where the public healthcare
system has collapsed or provision is reduced (often af-
fecting the most marginalised communities), whether in
everyday settings in much of the global south or during
disasters or crises.
As NGOs work with the patient groups, they are also
increasingly involved in advocacy to influence health
policy and education to ensure the capacity and sensitiv-
ity of health workforces and systems to address the
needs of the community [4, 46, 47]. For example, NGOs
perform independent reviews of services or reports on
humanitarian crises. As such, NGOs have an opinion-
forming role, sometimes formalised in the guise of think
tanks, in addition to the roles of service delivery and
monitoring. These varied operations illustrate NGOs’ di-
verse potential engagement with HPSR as the end-user
(the implementer) and/or funder, data source, author or
collaborator. As such, they are a key stakeholder in
HPSR – they can inform the HPSR research agenda,
benefit from HPSR research, and disseminate HPSR
findings to the study populations and other non-
academic stakeholders [48, 49].
Despite the obvious potential mutual benefits and
shared aim of improving health outcomes, challenges to
the use of NGO data by academics and NGO–academic
collaboration remain and are well documented [7, 11, 15,
50]. Concerns include time and funding for collaboration,
lack of methodological rigour and poor data quality [18,
51, 52]. For example, the timeframes of academics and
NGOs can differ as the NGOs often prioritise developing
trust and collaboration with the patient group whilst
academics may be more concerned with data collection
over a short time period [53]. Another example is the
pragmatic data collection that NGOs tend to employ,
rather than being concept or research-question driven.
This can result in data that are inconsistent or partial, with
data sometimes collected in differing samples (e.g. loca-
tions), over different timeframes and not always available
in easily accessible formats [36, 54]. This causes practical
difficulties of aggregation and uncertainties in measures
and interpretation [6]. Academic concerns about second-
ary analysis of qualitative data, such as interviews or focus
groups more generally, and not just qualitative data
collected by NGOs include the inability to verify the
source and key characteristics, difficulties assessing and
addressing any bias in the data collection process, e.g. via
additional data collection, and the collection of data to fit
their research questions [55]. Despite these challenges, the
volume, access and often depth as well as the immediacy
of data generated by NGOs represent significant untapped
potential for secondary analysis, especially for population
groups where there is no other source of data [48].
Methods
A scoping review of existing published literature was
conducted following the framework initially outlined by
Arksey and O’Malley [56]. Scoping reviews aim to exam-
ine the extent, range and nature of research activity by
‘charting’ the key concepts underlying the research area
and the main sources and types of evidence available.
They are valuable for gaining a rapid understanding of
areas that are complex and/or have not been reviewed
comprehensively before.
We used the five core stages of the methodological
framework, namely (1) identify the research question; (2)
identify relevant studies; (3) select the studies; (4) chart
the data; and (5) collate, summarise and report the re-
sults. It was outside the scope of this review to perform
the optional ‘sixth stage’ consultation exercise to validate
the findings of the review. As a scoping review, breadth
rather than quality of the studies was prioritised. A qual-
ity appraisal was not performed [56].
Stage 1: identifying the research question
The primary objective of this review was to summarise
and critically appraise the extent to which NGO data
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have been used in HPSR in relation to the types of NGO
data used, the ways in which they have been used and
areas of HPSR to which they have been applied, and to
identify opportunities for greater use in future research
via secondary analysis. We seek to show how these data
are being used in the HPSR context and highlight their
potential for health system development, particularly in
developing countries [57].
Stage 2: identifying relevant studies
We performed a systematic search of papers published
between January 2010 and February 2019 in the databases
Web of Science, Scopus, Medline (OVID), and Health
Management Information Consortium (HMIC). A post-
hoc search was performed in Embase (Ovid) (Table 1).
Searching interdisciplinary databases (Web of Science,
Scopus) as well as those with a health focus (Medline,
HMIC) ensured a comprehensive and inclusive approach
as relevant papers were expected in journals for the
social sciences, particularly global development, as well
as health research. HMIC covers the areas of health ser-
vice policy, management and administration, and public
health. It contains information from DH Data (produced
by the United Kingdom Department of Health) and the
King’s Fund Information and Library Service database
but is not limited to United Kingdom-only research.
A broad search strategy was used to identify records
with an NGO key term (including community organisa-
tion/group, charity, civil society organisation) and the
terms health system, delivery or governance in the title,
abstract or key terms. The key terms used were informed
by the authors’ knowledge of NGOs, development and
health research in both high- and low-income countries.
To increase the sensitivity of the searches, the key terms
were mapped to subject headings, where possible. The
date range was restricted to manage the large number of
records retrieved by the strategy and to meet the research
objective for the contemporary HPSR arena.
Following the screening process (Stage 3 below), a fur-
ther post-hoc search was performed for the same period
in the database Embase (Ovid), which includes some
medical and related journals not indexed in Medline
(Ovid). This aimed to increase the number of studies
available for the review in response to concerns that the
initial strategy may have missed some studies, particu-
larly on health policy, or which used the key term ‘medi-
cine’ rather than ‘health’.
Stage 3: study selection
Titles and abstracts, followed by the full text of poten-
tially included articles, were screened according to the
inclusion criteria by at least two reviewers (SM, AM,
MB; only SM reviewed the citations identified via the
post-hoc Embase search). The article inclusion criteria
were (1) research that examines organisations, people
and actions whose primary intent is to promote, restore
and maintain health and health equity via appraisal of at
least one of the six WHO health system building blocks;
(2) data collected, produced by or about one or more
NGOs have been used to investigate the research ques-
tion; and (3) published in English in a peer-reviewed
publication. The use of NGO data was determined by
searching the main text and reference lists for references
to NGO data and assessing how it had been used in the
study/article.
The classification of NGOs can be problematic and
there is considerable debate surrounding the taxonomy
of NGOs. However, there is broad agreement that NGOs
can be defined – and are for this paper – through the
following shared structural and organisational features:
(1) private or non-state; (2) self-governing; (3) forma-
lised; and (4) not-for-profit organisations [58]. Multilevel
(a mix of NGO and state/regional government agencies)
and humanitarian organisations, such as the UN, WHO,
and International Committee of the Red Cross, are
exempt from this definition as their legal status and roles
are distinct from that of NGOs. Accordingly, data
collected and produced by these organisations were
excluded from our review.
Stage 4: charting the data
Information from the included studies was ‘charted’ by
the lead author (SM). This is the term used by Arksey
Table 1 The literature search strategies used in the different
databases
Web of Science: Topic = (“health” AND (“non-governmental” OR NGO*
OR “community organization*” OR “charity” OR “community group” OR
“civil society organization*”) AND (“governance” OR “system” OR
“delivery”)) Timespan: 2010–2019
Scopus: Title-Abstract-Keywords (“health” AND (“non-governmental” OR
NGO* OR “community organization*” OR “charity” OR “community
group” OR “civil society organization*”) AND (“governance” OR “system”
OR “delivery”)) AND PUBYEAR > 2009
Medline: Title-Abstract-Keywords = (health AND (non-governmental OR
NGO* OR community organization* OR charity OR community group OR
civil society organization*) AND (governance OR system OR delivery)
limit to yr = “2010”)
Health Management Information Consortium: Title-Abstract-
Keywords = (“health” AND (“non-governmental” OR NGO* OR
“community organization*” OR “charity” OR “community group” OR “civil
society organization*”) AND (“governance” OR “system” OR “delivery”)
limit to yr = “2010”)
Embase: Title-Abstract-Keyword = (“health” or “medicine”) AND (“non-
governmental” OR NGO* OR “community organization*” OR “charity” OR
“charities” OR “community group*” OR “civil society organization*”) AND
(“governance” OR “system*” OR “delivery” OR “policy” OR “policies”) limit
to yr = “2010”
Initial searches were carried out using Web of Science, Scopus, Medline and
Health Management Information Consortium. A post-hoc search was
performed in Embase in response to concerns that the initial strategy may
have missed some studies, particularly on health policy
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and O’Malley to describe the process of identifying,
recording and organising key items of information from
each study according to key issues and themes. To en-
able comparisons between many studies with diverse
study designs and contexts, the following information
was recorded for each study: NGO role in the publication
– author/co-author/other contribution; geographical con-
text – research setting (country/region); developed/devel-
oping country; HPSR area – the goal and applicable
WHO building blocks; study details –design (e.g. literature
review, case study, evaluation); study about NGO activities
(e.g. NGO programme evaluation) (Yes/No); primary data
collection in addition to secondary analysis (Yes/No);
NGO data – which named NGOs are referenced; data
type (e.g. an unpublished report, administrative informa-
tion about the NGO or NGO-collected data such as
patient records); data use (e.g. providing context, case
study or quantitative analysis); and health category – ac-
cording to the Health Research Classification System
(HRCS) [59].
Following the initial charting exercise, an additional
data extraction exercise was performed that focused on
one of the data categories – studies with secondary ana-
lysis of NGO-collected clinical data. To enable a more
in-depth appraisal of the strengths and limitations of the
NGO data and its secondary analysis in HPSR, data on
the study outcomes, data strengths and limitations were
extracted.
Stage 5: collating, summarising and reporting the results
Given the expected number of included studies with
minimal secondary analysis of NGO data, a pragmatic
approach to presenting the data was taken. Summaries
of different depths are provided to give an overview of
the limitations and opportunities of secondary analysis
of NGO data in published HPSR and more broadly to
highlight the assumption of its primary use (in the form
of unpublished NGO reports) as a supporting reference
and not as a potential source of data for more in-depth
analysis, as follows:
1) a brief descriptive summary of the corpus of
included studies – as a scoping review, this serves
to show the expected scale of the underuse of NGO
data in HPSR by summarising the extent to which
studies in this field use NGO data solely or mostly
as a contextual reference;
2) a more detailed description of the studies which
analysed the NGO data to some extent (excluding
studies that only used NGO data in the form of a
report as a contextual or corroboratory reference) –
this stage seeks to showcase the diverse types of
NGO data that have been used for HPSR, where
these data originate and how they are being used;
and
3) a qualitative analysis of the studies that performed
analyses on NGO-collected clinical data – this stage
enables a more in-depth investigation of the
opportunities for the secondary analysis of a specific
type of often rich data collected by health NGOs,
when and who is using these data.
During the study selection and data extraction stages
(3–5 above), the lead author (SM) made notes reflecting
on trends observed in the use of NGO data in HPSR and
the difficulties identifying NGO data and their use (e.g.
unclear attribution of data to NGOs). We provide a brief
summary of the opportunities and limitations of second-
ary analysis of NGO data that emerged as themes in
these notes. A discussion of the implications of the
results, gaps and opportunities follows.
Results
The search produced 8979 records, of which 238 studies
(2.7%) used NGO data to investigate an HPSR topic
(Figs. 1, 2, 3 and 4) and were included in the review. Of
these, 156 (66%) performed some secondary analysis of
NGO data (Figs. 5, 6 and 7); 13 included secondary ana-
lyses of NGO-collected clinical data (6% of all studies; 8%
of the studies performing secondary analysis) (Table 2).
Overview of all included studies
This overview describes all the studies that included NGO
data in research on a health policy and systems topic (n =
238). Most of the studies were conducted in single country
contexts (70%; n = 166). The remainder investigated HPSR
topics across multiple countries (either within the same or
different geographical regions, e.g. West Africa (14%; n =
34), or from a global perspective (16%; n = 37)) (Fig. 2).
Unpublished reports produced by NGOs were the most
common source of NGO data and were used in 76% of the
studies (n = 182; Fig. 3).
The NGO administrative data analysed in 22% (n = 29) of
the studies consisted of databases of NGOs, service infor-
mation (what service was provided, to whom and where),
service evaluation (programme coverage rates, outcome in-
dicator prevalence), and NGO financial accounts (e.g. [73]).
Other types of data analysed (14% (n = 27) of the studies)
included project plans, operational guidelines and data, e.g.
a framework for health needs assessment (n = 7) [74–80],
press releases and news stories (n = 5) [81–85], definitions
produced by NGOs (used as operational constructs in the
studies) (n = 4) [86–90], clinical guidelines and guidance on
clinical guideline development (n = 4) [74, 80, 91, 92], edu-
cational resources and information for clinicians (n = 3)
[93–95], unspecified contributions of background informa-
tion by NGO members (n = 3) [96–98], contracts (n = 3)
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Fig. 1 Flow diagram of the process of study selection
Fig. 2 Geographical context of the included studies by region. n = 238 studies; regions not mutually exclusive
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[76, 77, 99], an interview transcript (n = 1) [82], and work-
shop proceedings (n = 1) [100]. The clinical data analysed
in 5% of the studies were collected by NGOs via drug distri-
bution and treatment monitoring systems and health moni-
toring information systems (patient records).
Half the studies (50%; n = 120) exclusively performed
secondary analyses of available NGO data. The remain-
der performed additional data collection exercises for
the purposes of the study (n = 118). Many of the studies
were either literature reviews or had an initial review
component (34%; n = 81). As in the wider set of studies,
there was variation in the use of NGO data in these re-
view elements. Only a minority (35%; n = 28/81) found
and included grey literature (i.e. unpublished reports) in
the analysis (e.g. [26, 88, 101]) – the majority excluded
unpublished NGO-produced reports. Others included
means of identifying relevant grey literature in their
search strategies but did not find or exclude NGO re-
ports at the screening stage [102–104].
More commonly, NGO-produced reports were used
only as a supporting (corroboratory) reference or to pro-
vide a contextual detail, such as a statistic about the
study population. For example, in a document analysis
investigating armed conflict in Pakistan and the role of
NGOs in restoring health services, a report by (the
NGO) International Crises Group was used to support
Fig. 3 The types of NGO data used in the included studies. n = 238 studies; types of data not mutually exclusive. The ‘other’ category includes
press releases, clinical guidelines and workshop proceedings
Fig. 4 The methods of data use in the included studies. n = 238 studies; methods of data use not mutually exclusive. The ‘other’ category
includes using NGO data (e.g. reports) as guidance for programme development or to provide a definition
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the statement, “the destruction of health centers and kill-
ing and kidnaping of doctors by the terrorists have made
it more complicated for the locals to access basic health
facilities” [105]. Neither this, nor any other NGO reports
were included in the analysis. This is an example of cor-
roboratory reference use. In a study on the contributions
of aid organisations and international NGOs to health in
Nepal, an NGO report was used to state that Nepal is
ranked 146th out of 178 countries on the Corruption
Perception Index [106]. No NGO resources were in-
cluded in the literature review component of the study.
This is an example of contextual reference use.
Fig. 5 Research setting by UN World Economic Situation and Prospects Categorisation. n = 156 studies
Fig. 6 Classification by research area using the WHO health system building blocks framework [25]. n = 156 studies; research areas not mutually exclusive
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Of the studies, 35% (n = 82) had more than one differ-
ent use of NGO data (e.g. as a supporting reference in
the introduction and NGO-collected patient data in the
main analysis) (Fig. 4). As well as a range of different
types of NGO data used (qualitative and quantitative),
the extent of the secondary analysis of NGO data varied
from cursory to in-depth.
Overview of included studies with secondary analysis of
NGO data
The following summary is only for those studies that
performed secondary analysis of NGO data, excluding
studies that only used NGO data as a corroboratory or
contextual reference (n = 82 omitted (36% of the 238
studies included in the review); n = 156 included). Al-
most half of the studies (n = 156) investigated HPSR
topics in developing countries (Fig. 5) [107].
Using the WHO health system building blocks frame-
work, most of the studies (55%; n = 86/156) had the goal
of improving health via research on service delivery
(Fig. 6) [4]. For example, via evaluation of the role of the
NGO in health system delivery or the efficacy of scaling-
up an NGO-delivered service from the regional to
national level (e.g. [76, 108, 109]). The majority focused
on one building block (81%; n = 127/156); four examined
all six [26, 70, 110, 111].
There were studies relating to 15 of the 21 HRCS
categories. Most of the studies covered topics of generic
health relevance (57%; n = 89), followed by infection (e.g.
HIV, tuberculosis, sexually transmitted infection; 18%,
n = 28), and reproductive health and childbirth (10%;
n = 16) (Fig. 7). Eight were on mental health topics (only
two were conducted in developing countries – West
Africa and Lebanon [89, 112]).
NGOs had no stated involvement in the publication or
funding of 67% of the studies (n = 105). NGOs were the
sole author of 6% (n = 9) or co-author of 20% (n = 31) of
the studies and funded either the study or the researcher
in 7% (n = 11). Most of the studies with NGO authors or
co-authors included secondary analysis of at least one
source of their own data (78%; n = 31/40). NGO funding
of the studies authored by NGOs can be assumed and is
likely (but was not reported) for some of those co-
authored.
Summary of the findings for studies that used NGO-
collected clinical data
For a more detailed investigation of the use of NGO data
in HPSR, this summary presents the findings of the stud-
ies that performed secondary analysis of clinical data
collected by NGOs (n = 13).
NGO clinical data are data collected by NGOs
about the health of people using their services (e.g.
patient records) and not about their own activities
(e.g. NGO accounts and performance monitoring sys-
tems). These data, sometimes collected over a period
of many years and often in populations without ac-
cess to a national health system, result in unique and
longitudinal datasets, which can be used in a range of
exploratory and comparative studies [65, 113], for ex-
ample, to examine how the health and healthcare use
of marginalised population groups is different from
national patterns, how they change (in health, budgets
and service provision) over time and seasonal varia-
tions [23, 60, 114–117].
Of the 13 studies in this review that performed sec-
ondary analysis of NGO-collected clinical data, 69%
(n = 9) were studies in developing countries. As in the
preceding overview of the studies performing secondary
analysis, most of the studies using clinical data investi-
gated service delivery-related research questions (69%;
n = 9). Of the HRCS categories, most were of generic
Fig. 7 Categorisation of the studies by clinical area using the Health Research Classification System. n = 156 studies; clinical areas not mutually
exclusive – 10 studies (6%) investigated two or more categories
Masefield et al. Health Research Policy and Systems           (2020) 18:63 Page 9 of 22
Table 2 Summary of the characteristics and data used in the studies with NGO clinical data (n=13)
Author Country Name of NGO
(author/co-author)
NGO data (aadditional NGO
and/or other data used in
the study, including data
collection for the purposes
of the study)
Study population Outcomes using the NGO data Strengths and limitations
of the data reported in
the article)
Bini et al., Pharmacoepidemiological
Data from Drug Dispensing Charities
as a Measure of Health Patterns in a
Population not Assisted by the
Italian National Health Service [60].
Italy Banco Farmaceutico Drug dispensation records
(includes gender, macro-
region of birth, age,
duration of the illness)
Low income
population not
assisted by the
Italian National
Health Service
Highlighted differences in
health between those that do
and do not receive Italian NHS
assistance
Strengths: large dataset (87,550
subjects); complete data
Limitations: individual patient
data not provided so analysis
by group not possible
Carlson et al., Inequitable Access to
Timely Cleft Palate Surgery in
Low- and Middle-Income
Countries [61].
Ghana, Ethiopia,
Democratic
Republic of
Congo, and
Madagascar,
China, India,
Nicaragua,
Bolivia, Paraguay,
Peru, Mexico
Operation Smile
(co-author)
Patient records (includes
gender, age, diagnosis,
proposed surgical repair,
and documented
operation)
People without
access to cleft
palate/lip in low
and middle
income countries
Highlighted inequalities in
access to surgical care
Strengths: comprehensive initial
consultation so could select a
sample with specific
characteristics
Limitations: no high income
group comparison data
Cunningham et al., Occupational
Therapy to Facilitate Physical
Activity and Enhance Quality of
Life for Individuals with Complex
Neurodisability [62].
UK Royal Hospital for
Neuro-disability
(authors)
Patient and
therapist records
Individuals with
complex
neurodisability
and limited
physical activity
Demonstrates the role of
occupational therapists and
meaningful physical activity for
people with neurodisabilities
Strengths: none reported
Limitations: none reported
Deboutte et al., Cost-effectiveness of
caesarean sections in a post-conflict
environment: a case study of Bunia,
Democratic Republic of the
Congo [63].
Democratic
Republic of
Congo
NGO name not
reported
Patient records (includes
maternal deaths and
obstetric care)a
People with
limited access to
obstetric care in a
conflict-affected
country
Highlighted challenges to
service provision during
transition from NGO to national
health system healthcare, with
the need for additional support
from NGOs to ensure equitable
access
Strengths: adequate data to
compare the obstetric
characteristics of women who
lived in the same
neighbourhood and delivered
around the same time (e.g.
caesarean section versus virginal
delivery)
Limitations: limited
generalisability of the findings
to other crisis situations e.g.
sudden-onset natural disasters
Gurung et al., Large-scale STI
services in Avahan improve
utilization and treatment seeking
behaviour amongst high-risk groups
in India: an analysis of clinical records
from six states [64].
India Avahan (delivered by
a network of NGOs)
(co-authors)
Individual clinical
monitoring data (includes
sex, age, years in sex work,
symptoms, diagnosis)a
High risk groups
for sexually
transmitted
infection
Demonstrated the need for
services by high risk groups
and the ability to provide
treatment at a large scale
Strengths: none reported
Limitations: incomplete data
(missing dates, site, ID number)
Jacobs et al., From public to private
and back again: sustaining a high
service-delivery level during transition
of management authority: a
Cambodia case study [65].
Cambodia Enfants et
Développement
project taken over by
Swiss Red Cross (SRC)
(CRC co-author)
Patient data (includes child
vaccination and
birth-related information)a
People without
access to health
services during
transition to a
national health
system
Demonstrated how transition
from NGO to public service
delivery can be monitored and
achieved without a loss in service
capacity and quality
Strengths: none reported
Limitations: lack of controls for
comparison with the study
sample
M
a
se
fie
ld
et
a
l.
H
ea
lth
R
esea
rch
P
o
licy
a
n
d
System
s
          (2
0
2
0
) 1
8
:6
3
 
P
a
g
e
1
0
o
f
2
2
Table 2 Summary of the characteristics and data used in the studies with NGO clinical data (n=13) (Continued)
Author Country Name of NGO
(author/co-author)
NGO data (aadditional NGO
and/or other data used in
the study, including data
collection for the purposes
of the study)
Study population Outcomes using the NGO data Strengths and limitations
of the data reported in
the article)
Kohli et al., A Congolese
community-based health program for
survivors of sexual violence [66].
Democratic
Republic of
Congo
Foundation
RamaLevina (FORAL)
(co-author)
Patient records (includes
demographics, experience
of sexual violence, physical
and mental health
problems, treatment)a
Survivors of
sexual violence in
a conflict-affected
country
Demonstrated the need and
ability of mobile health services
to support and strengthen
existing services by reaching
rural and conflict-affected
populations
Strengths: none reported
Limitations: limited data
collected as new clinical form
designed to minimise the
burden of documentation for
patients and clinicians
Lindgren et al., Using mobile clinics
to deliver HIV testing and other basic
health services in rural Malawi [67].
Malawi Global AIDS Interfaith
Alliance (GAIA) (co-
author)
Patient data (presenting
illness)a
Rural
communities
without access
to HIV services
Demonstrated the need and
effective monitoring of mobile
clinics in remote rural villages
and seasonal variation
Strengths: clinical forms
well-matched with the
government-run health centre
records so comparison possible
Limitations: inconsistent data
recording (e.g. not all sites
distinguished between
dysentery and diarrhoea)
Marsden et al., Risk adjustment of
heroin treatment outcomes for
comparative performance assessment
in England [68].
UK NGO name not
reported (NGO-run
services contribute
data to the national
monitoring system)
Drug treatment records
(includes history and current
substance use, health and
social functioning,
demographic information)a
Substance users
in a high income
country
Highlighted variation in good
and poor practice across the
UK so inequalities can be
addressed
Strengths: comprehensive
individualised data which can
be stratified by site
Limitations: none reported
Odwe et al., Introduction of
Subcutaneous Depot
Medroxyprogesterone Acetate
(DMPA-SC) Injectable Contraception
at Facility and Community Levels:
Pilot Results From 4 Districts of
Uganda [69].
Uganda Reproductive Health
Uganda
Patient recordsa Women receiving
contraceptive
services
Quantified the volume of
contraceptive methods
provided at NGO clinics
Strengths: none reported
Limitations: absence of unique
patient identifiers for data from
every clinic (including village
health teams and mobile
outreach).
Poenaru, Getting the job done:
analysis of the impact and
effectiveness of the SmileTrain
program in alleviating the global
burden of cleft disease [70].
Global SmileTrain Patient records (includes
surgical procedures)
People without
access to cleft
palate/lip in low
and middle
income countries
Highlighted the global burden
of disease caused by delayed
surgery
Strengths: large multi-country
dataset
Limitations: dataset needs to be
combined with additional data
sources for verification; not
representative of the LMIC cleft
palate/lip population as 79/171
LMICs represented
Ruckstuhl et al., Malaria case
management by community health
workers in the Central African
Republic from 2009–2014:
overcoming challenges of access and
instability due to conflict [71].
Central African
Republic
The MENTOR
(co-author)
Community health worker
records (includes basic
demographic information,
symptoms, test results,
treatment)
Malaria-endemic
region of a
conflict-affected
country
Highlighted specific local
context issues: variation in
malaria trends between the
seasons and during periods of
conflict
Strengths: longitudinal data
(2009 to 2014)
Limitations: Incomplete data
(not reported during peaks in
violence); data collection tools
not implemented across sites
simultaneously
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Table 2 Summary of the characteristics and data used in the studies with NGO clinical data (n=13) (Continued)
Author Country Name of NGO
(author/co-author)
NGO data (aadditional NGO
and/or other data used in
the study, including data
collection for the purposes
of the study)
Study population Outcomes using the NGO data Strengths and limitations
of the data reported in
the article)
Wendland et al., Undocumented
migrant women in Denmark have
inadequate access to pregnancy
screening and have a higher
prevalence Hepatitis B virus infection
compared to documented migrants
in Denmark: a prevalence study [72].
Denmark Unnamed NGO
(which runs clinics
providing healthcare
to undocumented
migrants)
Patient recordsa Undocumented
migrant women
aged 18-45
Prevalence of pregnancy and
sexually transmitted infection
Strengths: the ability to
conduct research in a
population who do not
engage with national health
services
Limitations: limited
generalisability (do not know if
the sample (women presenting
to a clinic) were representative
of the study population
(e.g. more/less healthy)); some
missing data (test results)
M
a
se
fie
ld
et
a
l.
H
ea
lth
R
esea
rch
P
o
licy
a
n
d
System
s
          (2
0
2
0
) 1
8
:6
3
 
P
a
g
e
1
2
o
f
2
2
relevance (39%; n = 5), followed by infection (23%; n = 3)
and reproductive health and childbirth (15%; n = 2). The
characteristics and use of NGO data in these studies are
summarised in Table 2.
Emergent themes
Notes reflecting on the studies and NGO data identified
were made by the lead author during the screening
process and analysis of the 238 studies and were
discussed with the co-authors. To conclude the results
section, emergent themes from these notes and discus-
sions are described with indicative references. The
themes largely arise from the disjunct between our un-
derstanding of the significant role of NGOs in health
policy and systems and the perceived underuse of these
data, given the sheer amount being collected and gener-
ated by health NGOs but not used in research.
Indeed, several studies included in our review were either
aimed at ascertaining just how great the contribution of
NGOs was in specific fields, (e.g. surgical practice, cancer
care and lesbian gay bisexual and transgender health services
[118–120]) or the scope for greater collaboration between
NGOs and others (e.g. business, multilateral and other
NGOs) [45, 81, 121, 122]. This research derives from the
knowledge that there are large numbers of health NGOs
worldwide but there is limited knowledge of the extent of
their activities (outside the organisation) [105, 123–125] and
barriers to partnerships [81, 122, 126].
When grey literature was included in reviews or as
background information, we observed a tendency for
authors to look to large, usually international and some-
times national, NGOs and multilevel organisations for
information in the form of reports, rather than looking for
information from small but potentially highly relevant re-
gional (or national) organisations (e.g. [88, 127–129]).
None of the studies that report searching NGO websites
for relevant documents list the NGOs or search strategy
used (e.g. [102, 130]). Furthermore, we noted that even
studies wholly or partially about NGOs and their health-
related activities sometimes did not include (or attribute)
any NGO-produced or collected data (e.g. [131–135]). For
example, one study exclusively reviewed grey literature on
the mental health and psychosocial response to the 2015
earthquake in Nepal, which they obtained through online
information-sharing platforms and response coordinators.
Although this paper mentions the work of NGOs, and we
can assume that some of the 168 documents included in
the review were produced by NGOs, there is no attribu-
tion of these resources (therefore, this review was ex-
cluded from our study) [136]. Developments in these
areas could both provide opportunities to improve health
in the communities where NGOs operate and facilitate
HPSR via data sharing and influencing data collection.
NGO data use
NGOs that are embedded in a community or act in the
context of an emergency or crisis and provide a valued
service, are likely to be trusted and have access to key
stakeholders, enabling exploratory research on sensitive
or contentious issues [66, 117, 137, 138]. The collection
of data ‘in the field’ enables evaluation of the efficacy of
interventions and services in the real world and differing
clinical settings, adding to the data from clinical trials
and to support service scale-up [61, 139–141]. These
data can also be used to show the extent to which health
systems and other development targets are being met
(e.g. by mapping changes in health outcomes against de-
velopment goals), by highlighting deficits and increasing
pressure for these goals to be achieved [26, 142, 143].
However, only two papers used NGO data for perform-
ance monitoring in this way [26, 144] and none refer-
enced Sustainable Development Goal (SDG) 3, which
outlines targets to ensure healthy lives and promote
wellbeing at all ages [145].
Although there were examples of the secondary ana-
lysis of NGO data, the number of studies doing so was
relatively small given the amount of data inevitably col-
lected and/or generated by NGOs. The effective use of
NGO-collected and produced data in published HPSR
shows that NGO data can be accessed and used by re-
searchers to answer HPSR questions but is largely not
[146]. NGOs with a research agenda, who might be
more aware than academic institutions of the data col-
lected by other NGOs or have established partnerships
with other NGOs (e.g. joint service delivery or members
of the same NGO network organisations), also appear
reticent to use other NGOs’ data. For example, of the
studies with NGO authors or co-authors (indicating a
research agenda/interest), only four (15.4%; n = 26)
either performed a secondary analysis of data collected
by another NGO or referenced literature by other NGOs
[86, 108, 147, 148]. One of the included studies found
that NGOs may be less likely than the academic and
public sector to draw on the expertise of others, includ-
ing other NGOs, in the production of Health Impact As-
sessments [149]. The same could be true for other areas
of health research.
Identification and limitations of NGO data
It was not always easy to identify which NGO’s data
were being used and where the data had been acquired.
In the studies, it was common practice to name an NGO
and state their aims, scope, etc. but not to link to their
websites, thereby not attributing the (most likely) source
of the data (e.g. [132]). It was often not clear how much
of the data were provided by NGO-delivered services,
particularly when documents or case studies were ana-
lysed (e.g. [68, 96, 150, 151]). These practices result in
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the under-acknowledgment of NGO data in HPSR stud-
ies. An example of appropriate, yet limited, attribution
was demonstrated by Cancedda et al. [110], who refer-
enced the ‘Our Work’ section of the website for the
NGO used as a case study (and co-author) in the re-
search article. However, it remained unclear whether the
co-author from the NGO (Partners in Health) was the
primary source of the data used in the evaluation or
whether NGO-produced (internal and/or external) docu-
ments and the website were the main source.
Limitations of NGO data were reported in some of the
238 included studies. In some instances, NGOs may be
commissioned or tendered to provide a service within a
country’s national health system. The synthesis of data
across NGO and health system services was hampered by
using different record-keeping systems that did not all rec-
ord the same data or in the same way or data recording
was incomplete for some services [77, 115, 152, 153]. This
issue may be even greater where services are rolled out to
new communities without consistent record-keeping and
electronic data monitoring systems [64, 115].
Data collected by NGOs in challenging geographical
areas or amid humanitarian crises were largely designed
for practice and not for research [63, 67, 147]. There
may be limited data collection and incomplete or in-
accurate data [65, 72, 116], or researchers may not be
fully aware what data have been collected and may be
available. Elements of rigorous research are often
neglected as an NGO’s first consideration is to treat and
support the population in need by acquiring only essen-
tial information [38]. Adequate descriptions of the con-
text, intervention and/or strategy, control groups and
randomisation for intervention studies and generalisabil-
ity were largely absent in the studies [71, 116, 154].
However, we note that claims about data limitations
attributable to NGOs are not valid in all contexts. For
example, health surveillance information collected by
NGOs and other healthcare providers in the Central
African Republic is inconsistent as disease screening
programmes have been erratic in some regions due to
security issues [155]. In a study on undocumented mi-
grants visiting health clinics in Denmark, the generalis-
ability of the findings was limited by the lack of data for
the wider undocumented migrant population [72]. In
both instances, the data limitations were outside the
control of the NGO that provided the data for the
studies.
Knowledge of these data limitations or concerns about
the quality of the research using them are possible expla-
nations for the limited use of NGO data in HPSR.
Discussion
This review is the first, to our knowledge, to use a sys-
tematic method to provide a comprehensive examination
of how data collected and produced by NGOs are being
used in HPSR and the extent to which secondary
analyses of these data are being performed. We found
evidence of the analysis of NGO data in HPSR in 66% of
the studies included in the review (n = 156). NGO-
produced reports were the most common form of data
used (in 64% of the studies) but with limited analysis of
these data (e.g. their use to critique the NGO’s activities
or provide a brief example). Only 8% of the studies per-
formed detailed analyses that used clinical data collected
by NGOs. When the scale and diversity of NGO practice
(and therefore data collection) and the potential value of
NGO data to research are considered, our results indi-
cate limited use of secondary analysis of NGO data. The
use is limited both in the quantity of studies and the
depth of analysis.
For a majority of HPSR topics, relevant data are being
collected by NGOs and could be used to answer, or con-
tribute to answering, research questions of relevance to
both NGOs and academics either as a primary or sup-
plementary data source (i.e. action research). The oppor-
tunities for NGO data use lie far beyond the use of
unpublished reports as supporting references. Our study
highlights the frequency of this minimal use of NGO
data as well as some innovative uses of NGO-produced
data, for example, NGO administrative data to assess the
scale (and spending) of NGO operations to learn more
about the contribution of NGOs to world health [77,
108, 156, 157]. We highlight the value of NGO-collected
data for research in hard-to-reach populations, including
undocumented migrants, people experiencing domestic
violence and in conflict-affected areas (e.g. [105, 117,
158, 159]). Therefore, while some researchers are acces-
sing and performing secondary analysis on NGO data, it
is our view that real and perceived barriers to NGO–
academic collaboration and NGO data access result in
the entrenched underuse of NGO data in HPSR. This
view is shared by others working in development re-
search [7, 11, 15–17, 32, 48, 50, 57, 160].
As expected, NGO data use in HPSR, beyond inclusion
as a corroboratory or contextual reference (n = 156 stud-
ies), occurred in studies with NGO authors/co-authors
(26%), in developing countries (48% of studies), with the
aim of evaluating a service delivered by NGOs (55% of
studies), and in clinical areas of generic health relevance
(57%). Our review was not able to identify why re-
searchers do not perform secondary analysis of NGO
data, although some of the challenges that they face
when using NGO data were highlighted in Table 2,
namely incomplete, inconsistent or aggregated data and
lack of control/comparison groups drawn from the same
population. We can, however, identify opportunities
based on examples of the successful use of NGO data
and suggest how its underuse might be mitigated to
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encourage more routine use of this largely untapped but
highly valuable resource. The following discussion draws
on the studies included in our review and the wider lit-
erature on NGO data and NGO–academic collaboration.
Opportunities for NGO data use
The population groups for which secondary analysis of
NGO-collected clinical data (n = 13) were performed were
all marginalised groups with restricted access to health-
care services, such as rural communities, people affected
by conflict, and violence or drug addiction. It is highly
likely that the clinical data collected by NGOs, whilst pro-
viding a valued healthcare service, were not collected for
research purposes but were the best, and possibly only,
source of data for these groups [6, 13]. Therefore, using
NGO data (and collaboration with NGOs to collect data)
is an opportunity to raise awareness of health issues in
groups who are often overlooked or hard to reach by aca-
demic researchers [38, 161]. This may be the case espe-
cially in developing countries with challenging political
and/or cultural contexts and where there may be stigma
associated with certain health conditions such as sexually
transmitted diseases [11, 66, 117]. NGOs may also be in a
better position, in terms of trust, to obtain these sorts of
data [113].
Greater use of NGO data could have a particularly im-
portant role to play in increasing awareness of health
conditions, health needs and health service use for mar-
ginalised groups and reducing the inequalities experi-
enced by these groups. For example, the use of NGO
data could provide new insights into disparities in the
health of marginalised groups compared with the general
population, which could inform the development of pol-
icy and potential interventions, as well as being used
more extensively in programme and facility evaluation
and advocacy [38, 109, 162].
Some of the studies we analysed used longitudinal
NGO data. These are extremely valuable for monitor-
ing changes in health over time and are important in
the context of determinants of health, including chan-
ging social, economic and environmental conditions
[163]. Longitudinal data are especially valuable when
environmental and political changes are occurring at
an unprecedented rate such as in humanitarian crises.
Conducting long-term studies has substantial cost im-
plications that all organisations face. Accessing avail-
able longitudinal data sets produced by NGOs can
facilitate the research of interest whilst limiting the
costs for research institutions [6]. In other cases,
NGOs work with a community for a relatively short
period of time, ceasing activity when donor funding
ends. It is important that the benefits of these data are
realised, not least because demonstration of impact
can support requests for further funding [54, 160, 164].
Longitudinal data are also important for conditions
that develop over time or may be rooted in childhood or
mental health conditions [141, 163]. However, only eight
of the studies that performed secondary analysis on
NGO data (n = 156) addressed mental health topics and
only two in developing countries. This is perhaps not
surprising as, despite mental health accounting for 27%
of all years lived with disability worldwide, mental health
has received far less interest in research and practice in
developing than developed countries [165, 166]. The evi-
dence of an absence of available (including NGO) data
in these contexts can also help build the case for funding
for, for example, the scaling up of NGO service delivery
and research activities (including to collect better quality
data) in these (developed and developing country) loca-
tions [45, 167, 168]. The assumption (and sometimes
reality) of poor-quality data is a common academic
explanation for not attempting secondary analysis of
NGO data [8]. However, it is not true of all NGO data
[148]; for example, the NGO, Reproductive Health
Uganda, provides training on data collection, storage
and reporting to ensure minimum data standards across
their network of 17 health clinics [69]. Entering into
collaborations with NGOs working in the field of inter-
est can benefit both partners in their shared aim of
improving health outcomes [11, 17, 167]. NGO data and
NGO–academic collaboration can be particularly valu-
able in action research, especially within the contexts of
refining approaches to achieve the SDGs and developing
research methods to collect high quality data in challen-
ging settings [48, 49, 52]. HPSR is increasingly using the
SDGs as a framework for agenda-setting [8]. NGO data
can be used for measuring progress against SDG targets,
not least because health intersects with many other areas
of development [36, 145, 169].
Collaboration could also help the HPSR based on
NGO data to be disseminated faster, especially in disas-
ter or conflict areas. For example, most of the oper-
ational research on the Ebola outbreak from March
2014–December 2017 was published after the WHO had
initially declared the outbreak over in January 2016 ra-
ther than during the outbreak [170]. NGO–academic
collaboration could possibly have enabled analysis and
dissemination of the data from these contexts to the
Ebola research community and NGOs operating in the
field sooner, more rapidly advancing understanding of
the disease and policies to respond to outbreaks [170].
The benefits of collaboration for academics include
accessing NGO data that provides them with an oppor-
tunity to influence data collection tools and methods to
improve data quality and relevance for their purposes
[11]. For example, academics can work with NGOs to
help ensure that data are collected in a way that means
they are consistent over time and can be used for
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temporal analysis [63, 67]. Academics need to recognise
the potential of the data whilst accepting the inevitable
limitations of data collection by non-academics in chal-
lenging settings, with changing social and environmental
landscapes, aiming to collect only essential information
[64, 66, 71, 113].
The lack of experience of many NGOs in data hand-
ling and management can also limit the further use of
their data, but this is another area where there can be
positive sharing of best practice leading to improved
capacity over time [13, 15, 32]. In addition, for re-
searchers, secondary analysis provides the benefit of
being able to assess data quality prior to performing the
analysis [148]. The process of appraising NGO data has
time and cost implications, but much can be learnt by
academics, such as what additional data collection activ-
ities are required and how their research questions can
be adapted based on the available data [34].
Through collaboration, an NGO develops its research
capacity, the ability to evaluate its activities and can influ-
ence its partners’ research agenda. The ability to produce
evidence of local health needs and deficits in service
provision can also strengthen NGOs’ advocacy for health
policy and funding reforms from governments and donors
[6, 57]. Developing research (and importantly, evaluation)
capacity has been shown to facilitate the sustainability and
scaling-up of NGO activities [167, 171, 172]. However, in
the year 2000, only 23% of 37,000 international NGOs
were performing research activities (no more up-to-date
data were available). Explanations for limited or no collab-
oration with academic institutions include suspicion of
the academics’ agendas (including competing interest and
power inequalities in decision-making about the ethics,
purpose, application and dissemination of the research [7,
32, 173]); power and global north–south inequalities
[174–176]; and doubts about the value of communicating
with academic audiences [167, 171, 172]. Issues of com-
peting interests can arise between what data collection are
considered necessary by the NGO (e.g. to treat or monitor
health in the population) versus by the academics (i.e. to
produce high quality, publishable research), the ownership
of this data and linkage between new and existing data
collected [32, 173, 177, 178].
We advocate for greater NGO–academic collabor-
ation. The sharing of data could work both ways as,
through collaboration, NGOs that perform research
could benefit by accessing other datasets such as those
collected by academic or public sector institutions [179].
NGO–NGO, NGO–business and NGO–public sector
collaborations can also help develop research capacity
(and programme evaluation), thus facilitating the collec-
tion and use of NGO data in HPSR [121, 172, 180, 181].
Developing and implementing data standards and pro-
tocols to be adopted by (or together with) NGOs could
be a way to enhance the wider use of the data they col-
lect. Secondary data analysis requires the NGOs to grant
permission and re-issue data for another purpose than
originally intended. We are aware of the increasingly
stringent ethical requirements constraining research
organisations [182, 183]. The absence of ethical stan-
dards informing the collection and management of data
by NGOs (or equivalence of this governance to the
standards used by research institutions) may prohibit the
use of NGO data by academics [184]. The need for stan-
dardised data protection and for inter- and extra-NGO
sharing procedures is a current debate for humanitarian
and development agencies [185, 186]. Given the poten-
tial importance of NGO data for raising attention of
marginalised groups and calls for data interoperability
(joined up data) to achieve development goals [187], dif-
ferences in methodological protocols and data standards
can prevent the conditions of marginalised groups being
brought to wider attention [50]; this could maintain in-
equalities or even exacerbate them.
During the review, we found many instances of the
under- or ambiguous acknowledgement of NGO data in
various forms. Some studies stated that the data were
provided by an NGO or that a number of NGOs had
been involved in the data collection but did not provide
their names. Examples include referring to “the NGO
forum of Cambodia” (comprised of several unnamed
NGOs) [188], stating that “six of the nine data providers
in the study were NGOs” but giving no further details
[77], and acknowledging contributions by NGOs but not
stating whether they provided data [97]. Elsewhere,
NGO activities were used in case studies or given as ex-
emplars (e.g. [96, 189]), sometimes using information
from their websites (e.g. [190]). Oftentimes, these data
were either not attributed in the references (thus the
study becomes the de facto data source) or the reference
was for another source where the data had been reported
(i.e. not the original source of the data) [189]. Two studies
refer to data on funding received by NGOs but, as they do
not reference the source(s) of this NGO administrative
data, the study becomes the source [106, 126]. Further,
when an example of a specific NGO activity is used in a
WHO publication and this publication is referenced,
WHO becomes the data source and not the NGO.
By not attributing the NGO directly, inequalities of
knowledge and power between NGOs and research or-
ganisations, multilevel or network organisations such as
WHO, the UN, World Bank and are upheld [53]. This
failure to attribute research to NGOs was also seen
when the Global Health Watch Report 4 [191], which
has NGO and NGO network co-authors (e.g. Health Ac-
tion International and the People’s Health Movement),
was cited [23]. However, it is worth noting that collabor-
ation between NGOs and multilevel organisations does
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enable NGO research capacity and can raise the profile
of their activities. For example, Kilic et al. [192] refer to
documents on the healthcare system monitoring activities
of the Turkish Diabetes Foundation, which were jointly
published by the Turkish Ministry of Health, WHO
Europe and the International Diabetes Federation of
Europe. The multinational and multilevel organisations
may have assisted the Turkish Diabetes Foundation with
publication if they did not have the capacity or resources
to publish these documents independently. Their support
with dissemination could also greatly increase the reach of
these documents. Whatever the reason for this and similar
NGO–multilevel organisation collaborations, we would
stress the need for greater transparency in data use, clarity
in relation to source attribution, and appropriate and full
acknowledgment of NGO data and contributions [32].
Our analysis has focused on published research litera-
ture, but NGO research is more prevalent in grey litera-
ture, as demonstrated by the number of studies using
unpublished NGO literature as contextual or corrobora-
tory references. The relevant grey literature is harder to
locate, leading researchers to use the pragmatic strategy
of reference list searching and looking for relevant docu-
ments on the websites of organisations that they know
to work in the field of interest [79, 193–196]. This prac-
tice perpetuates imbalances in the visibility of research
by large NGOs and multilevel organisations compared
with smaller, less well-known NGOs [197]. There are
search tools and guidelines for searching grey literature,
but the academic preference for using peer-reviewed
published literature in formal reviews remains [198]. If
grey literature was more routinely included in literature
reviews in HPSR, researchers would find more NGO-
produced (unpublished) reports that may contain valu-
able data for inclusion in literature syntheses. The inclu-
sion of these references could be particularly beneficial
in areas with little published research (e.g. in margina-
lised groups) or areas dominated by published research
from high-income countries (e.g. mental health). Given
the more common use of reports produced by multilevel
or international NGOs, systematic searches of grey lit-
erature and use of the unpublished data identified could
also help raise awareness of research activities by smaller
NGOs. This increased exposure could also help them at-
tract funding and academic collaborators to grow their
research capacity [15].
We recognise that a review of this nature inevitably has
limitations. We performed a literature scoping exercise
across a range of interdisciplinary and health-specific
databases, favouring a broad search strategy in a few key
databases rather than a more focused strategy in every po-
tentially relevant database. We may also have missed some
relevant studies due to the under-acknowledgement of
NGO contributions, the challenge of identifying whether
named organisations fitted the NGO definition and the in-
clusion of only studies published in English. All of this
points to the importance of further research in this field to
examine in more depth the value of different types of NGO
data identified here but not investigated in detail. Greater
rigour in data sharing agreements and more systematic ac-
cess to the data collected by NGOs is also important. Add-
itionally, the comparison of practices of NGO data use in
other areas of development research could help researchers
begin to mitigate the issues of NGO data use in HPSR, e.g.
by adopting best practices and NGO–academic collabor-
ation standards used elsewhere [48].
We gave a broad overview of how NGO-collected and
produced data have been used and the extent of the second-
ary analysis of NGO data in HPSR, with a more in-depth
look at the use of NGO-collected clinical data. It was not
possible to provide a comprehensive analysis of how each
different type of data identified were used, although we iden-
tified some examples of innovative uses of NGO-produced
data such as NGO accounts. The public availability of elec-
tronic data produced by and about NGOs (including news
stories, financial information and court proceedings) is a
potentially rich seam for secondary analysis by researchers
willing to use less traditional data sources.
Conclusions
In this review, we have given an overview and specific ex-
amples of how, in HPSR, NGO-collected and produced
data are being used and in what contexts secondary ana-
lysis of NGO data is being performed. There were frequent
examples of the use of secondary analysis of NGO data in
service delivery evaluations, especially in developing coun-
tries and when the NGO is the author or co-author of the
study. To a lesser extent, we found examples of the use of
NGO-collected clinical data and NGO administrative and
other types of data published by researchers without any
(known) connections to NGOs.
We have argued that given the scale of health NGO
operations worldwide, NGO data constitute a vast and
valuable source of data for HPSR. Yet, the value of
these data is under-realised, and the data underused
and under-acknowledged in HPSR. By drawing on the
studies included in the review and wider literatures on
NGO data and NGO–academic collaboration, we have
offered suggestions for routes to the greater use of
secondary analysis of NGO data in HPSR. These in-
clude the routine inclusion of grey literature in litera-
ture reviews and greater NGO-academic collaboration
that is informed by clear and agreed standards for
research protocols, ethics and data management. With
its broad scope, this review offers an entry point for
further discussion of how secondary analysis of NGO
data can be used more extensively in HPSR and other
areas of research driven by development goals.
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